Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations

Michael Charles Ferguson Hannay, Chief Product & Supply Chain Officer of Bicycle Therapeutics PLC, sold shares to cover statutory tax withholding obligations.

Summary

• On April 2, 2025, Michael Charles Ferguson Hannay, the Chief Product & Supply Chain Officer of Bicycle Therapeutics PLC, sold 467 ordinary shares at a weighted average price of $8.02.
• The shares were sold to cover statutory tax withholding obligations related to the vesting and settlement of restricted stock units.
• Following this transaction, Hannay directly owns 54,813 ordinary shares.
• On April 3, 2025, Hannay sold 266 ordinary shares at a weighted average price of $7.48.
• Following this transaction, Hannay directly owns 54,547 ordinary shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover taxes) and doesn't inherently indicate positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Bicycle Therapeutics PLC, BCYC, Michael Charles Ferguson Hannay, Chief Product & Supply Chain Officer, Form 4, Share Sale, Tax Withholding, Restricted Stock Units, Beneficial Ownership